[1] |
Xiaowei Chi, Qi Li, Yi Zhong, Tong Gong, Chuxiao Yi, Liangren Zhang, Zhenming Liu.
Discovery of potential xanthine oxidase inhibitors based on virtual screening
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(8): 626-635.
|
[2] |
Wenjing Ta, Ruochen Hua, Xingyue Li, Jihong Song, Wen Lu.
In vitro blood-brain barrier models from different species: an overview on permeability associated with drug delivery
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(4): 237-249.
|
[3] |
Limei Yang, Liman Wang, Xuhui Huang, Jie Zhuang.
Warfarin affects the proliferation and apoptosis of lung cancer cells by regulating the Gas6/Axl/PI3K/Akt/NF-κB pathway
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(3): 190-199.
|
[4] |
Zhi Rao, Yuhui Wei.
A cell-combining-oriented phytochemical screening strategy using triple quadrupole mass spectrometry for the investigation of potential bioactive candidates in Chinese traditional medicine preparation Xiao-ai-ping injection
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(2): 101-111.
|
[5] |
Aris Stiawan, Eti Nurwening Sholikhah, Yehezkiel Steven Kurniawan, Yoga Priastomo, Jumina.
Synthesis, cytotoxicity assay, and molecular docking study of hydroxychalcone derivatives as potential tyrosinase inhibitors
[J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(8): 634-644.
|
[6] |
Guifang Duan, Bo Xu, Xia Yuan, Shuxiang Song.
High-throughput screening technologies for ion channel drug discovery
[J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(10): 785-793.
|
[7] |
Chennan Liu, Qian Wang, Jiangxue Han, Sihan Liu, Chunling Xiao, Yan Guan, Xinghua Li, Ying Wang, Xiao Wang, Jianzhou Meng, Maoluo Gan, Yishuang Liu.
Virtual screening and high-throughput testing of L1 metallo-β-lactamase inhibitor
[J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(10): 806-812.
|
[8] |
Man Liu, Shuang Zhang, Zhuoyue Li, Guangxue Wang, Jingru Wang, Xuan Zhang.
Preparation and characterization of zinc oxide nanoparticles
[J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(9): 617-625.
|
[9] |
Chengqun Li, Xia Niu, Jiahui Mu, Xiaomei Wang, Jin Su, Guiling Li.
Preparation and in vitro evaluation of APT011-loaded sustained-release microspheres
[J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(8): 554-563.
|
[10] |
Hua Deng, Chao Gao, Dengguo Wei, Sisi Liu.
Virtual screening for triple-negative breast cancer cell inhibitors based on telomere G-quadruplex structure
[J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(6): 383-389.
|
[11] |
Xiaoxin Liu, Xiaoya Qin, Ziyuan Li, Tianyuan Fan.
Microwave-assisted preparation and in vitro characterizations of doped superparamagnetic ferrite nanoclusters
[J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(3): 153-160.
|
[12] |
Fei Yu, Wenli Zhou, Jiayi Kan, Can Peng.
Comparison of dissolution profile characteristics of 11 berberine hydrochloride tablet brands in different dissolution media
[J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(2): 102-112.
|
[13] |
Jiangxue Han, Chunling Xiao, Maoluo Gan, Xinghua Li, Ying Wang, Jiayin Zheng, Dongsheng Li, Chennan Liu, Yan Guan, Jianzhou Meng, Shuchao Huang, Yishuang Liu.
IMB-XH1 identified as a novel inhibitor of New Delhi metallo-β-lactamase-1
[J]. Journal of Chinese Pharmaceutical Sciences, 2019, 28(4): 238-246.
|
[14] |
Yanli Hao, Ting Zhong, Ruo Du, Hua Zhang, Bilin Liu, Xuan Zhang.
The cellular uptake and anti-tumor activity of conjugated linoleic acid-paclitaxel-loaded iRGD-modified lysolipid-containing thermosensitive liposomes
[J]. Journal of Chinese Pharmaceutical Sciences, 2019, 28(2): 121-133.
|
[15] |
Yang Zou, Yao Jin, Yuanhang Zhou, Chuyu He, Yunqiang Deng, Shidi Han, Chuhang Zhou, Xinru Li, Yanxia Zhou, Yan Liu.
Preparation and characterization of dual pH-sensitive polymer-doxorubicin conjugate micelles
[J]. Journal of Chinese Pharmaceutical Sciences, 2018, 27(8): 530-539.
|